menu
    • menu

    Company profile for Juvise Pharmaceuticals

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Juvise Pharmaceuticals, established in 2008, manufactures, distributes and markets its own branded pharmaceutical specialties active in various therapeutic areas, including oncology, cardiology and neurology-psychiatry. Juvise sells its products in 75 countries. It markets its own brand of nine pharmaceutical products for treating cancer, cardiovascular disorders, neurological-psychiatric diseases, and rheumatic disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Juvise PharmaceuticalsFrance Flag
    Country
    Country
    France
    Address
    Address
    149 blvd Stalingrad 69100 VILLEURBANNE
    Telephone
    Telephone
    +33 (0)4 26 29 40 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.juvisepharmaceuticals.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/juvise-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Juvisé Pharma Announces New Chairman and CEO
    Juvisé Pharma Announces New Chairman and CEO

    16 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260415884303/en/Juvis-Pharmaceuticals-Formally-Approved-the-Appointments-of-Frdric-Mascha-as-Executive-Chairman-and-Chairman-of-the-Supervisory-Committee-and-the-Nomination-of-Renaud-Sermondade-as-the-Groups-New-CEO

    BUSINESSWIRE
    16 Apr 2026
    Share Share
    Juvisé licenses J&J’s MS drug Ponvory for marketing outside North America
    Juvisé licenses J&J’s MS drug Ponvory for marketing outside North America

    27 Mar 2024

    // PRESS RELEASE

    https://juvisepharmaceuticals.com/juvise-pharmaceuticals-acquires-global-rights-excluding-us-canada-to-ponvory-and-opens-its-capital-to-bpifrance-and-pemberton/

    PRESS RELEASE
    27 Mar 2024
    Share Share
    Juvisé Pharmaceuticals completes €400m refinancing after acquiring Pylera rights
    Juvisé Pharmaceuticals completes €400m refinancing after acquiring Pylera rights

    05 Jul 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/juvis-pharmaceuticals-completes-400m-refinancing-after-acquiring-pylera-rights-10620.pdf

    PRESS RELEASE
    05 Jul 2022
    Share Share
    Life Sciences team scoops seven LMG Life Sciences Europe Awards
    Life Sciences team scoops seven LMG Life Sciences Europe Awards

    05 May 2021

    // BUSINESSWIRE

    https://www.twobirds.com/en/news/press-releases/2021/global/life-sciences-team-scoops-seven-lmg-life-sciences-europe-awards

    BUSINESSWIRE
    05 May 2021
    Share Share
    The French speciality pharmaceutical, Juvisé acquires two onco products from AZ
    The French speciality pharmaceutical, Juvisé acquires two onco products from AZ

    20 Dec 2020

    // PRESS RELEASE

    https://www.juvisepharmaceuticals.com/wp-content/uploads/2020/04/Press-Release-Dartmouth-20122019-Eng-Juvis%C3%A9-Final.pdf

    PRESS RELEASE
    20 Dec 2020
    Share Share
    Juvisé Pharmaceuticals: An atypical player in the world of pharmacy
    Juvisé Pharmaceuticals: An atypical player in the world of pharmacy

    14 Dec 2020

    // BFMTV

    https://www.bfmtv.com/economie/replay-emissions/hashtag-jmleco/juvise-pharmaceuticals-un-acteur-atypique-dans-le-monde-de-la-pharmacie_AV-202012140119.html

    BFMTV
    14 Dec 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search